Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
06/2010
06/10/2010US20100144588 Proton acceptor iminium/carbocation-type coupling agents
06/10/2010CA2745121A1 Morpholinone compounds as factor ixa inhibitors
06/09/2010EP2193781A1 Hair dye and hair dye composition
06/09/2010CN1662511B Pharmaceutical salts of reboxetine
06/08/2010US7732449 preferential enzyme Inhibitors such as 4-(4-Acetyl-piperazin-1-yl)-2-(R)-cyclohexylmethyl-N-[1-(S)-methyl-2-(4-trifluoromethoxy-phenylamino)-ethyl]-4-oxo-butyramide, used for the treatment of inflammation, arthritis and atherosclerosis
06/08/2010US7732443 Prostaglandin derivatives useful in treating vision defects, inflammatory bowel disease and alopecia
06/08/2010US7732435 vanilloid receptor antagonists such as 7-(4-Chlorophenyl)-6-isopropyl-3-methyl-2,3-dihydro-1H-1-aza-4,5-dioxa-phenanthren-8-one, used for treating nociceptive pain; analgesics
06/03/2010WO2010062536A2 Modified actinomycin-based nucleic acid stains and methods of their use
06/03/2010US20100137583 Peptidomimetic protease inhibitors
06/03/2010US20100137316 Morpholine Compounds, Pharmaceutically Acceptable Salts Thereof, Pharmaceutical Compositions, and Methods Of Use Thereof
06/03/2010US20100137296 N-phenyl anthranilic acid derivatives and uses thereof
06/03/2010US20100137290 Oxazolidinone antibiotic derivatives
06/03/2010US20100137194 Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism
06/03/2010US20100133992 Compound comprising phosphorescence unit, emitting polymer and organic emitting device comprising the emitting polymer
06/02/2010EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone
06/02/2010EP1483228B1 Nk1 antagonists
06/01/2010US7728027 reacting 2-bromo-1-[4-[4-(2-bromoacetyl)phenyl]phenyl]ethanone with 1-(tert-butoxycarbonyl)-L-proline, then treating the product with ammonium acetate and deprotection to form chemical intermediates for viricides; cost efficiency; industrial scale
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727985 For therapy of inflammatory disease and cancer
06/01/2010US7727984 Medicaments for the treatment of chronic obstructive pulmonary disease
05/2010
05/27/2010WO2010032259A3 Process for the preparation of efavirenz
05/27/2010WO2010026110A3 6-substituted benzoxazines as 5-ht-5a receptor antagonists
05/27/2010WO2010019911A3 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions
05/27/2010US20100130486 Cyclic amine substituted pyrimidinediamines as pkc inhibitors
05/27/2010US20100130484 Novel bicyclic sulfonamide derivatives which are l-cpt1 inhibitors
05/27/2010US20100130471 Renin Inhibitors
05/26/2010EP2189451A1 Benzamide derivatives, their preparation and uses in medicine thereof
05/26/2010EP2187888A2 Bicyclic amides for enhancing glutamatergic synaptic responses
05/26/2010EP1438352B1 Low color, low sodium benzoxazinone uv absorbers and process for making same
05/26/2010CN1910137B Aryl aniline derivatives as beta2 adrenergic receptor agonists
05/26/2010CN1391469B Npyy5拮抗剂 Npyy5 antagonist
05/26/2010CN101110478B Electrode for fuel cell and fuel cell employing the electrode
05/25/2010US7723327 Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
05/25/2010US7723326 Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
05/25/2010US7722893 Use of substitute 2,4-bis (alkylamino) pyrimidines or quinzolines as antimicrobials
05/25/2010CA2440518C Method of producing n-substituted 2,6-dialkyl morpholines
05/20/2010WO2010056320A2 Pi3k/mtor kinase inhibitors
05/20/2010US20100125070 Bupropion Metabolites and Methods of Their Synthesis and Use
05/20/2010US20100125069 Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds
05/20/2010CA2743015A1 Pi3k/mtor kinase inhibitors
05/18/2010US7718653 Pyrimidine derivatives for inhibiting Eph receptors
05/13/2010US20100119709 Organic colorants and compositions containing same
05/12/2010EP2183229A1 Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
05/12/2010EP2183228A1 CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1
05/12/2010CN101704796A Preparation method of 3-morpholone
05/12/2010CN101704795A Hydrochloric acid 2-(1-ethyl propyl) moroxydine, preparation method and application thereof
05/11/2010US7714012 Synthesis and biological activities of new tricyclic-bis-enones (TBEs)
05/11/2010US7713968 Substituted arylcyclopentenes as therapeutic agents
05/11/2010US7713967 Therapeutic substituted hydantoins, and related compounds
05/11/2010US7713966 Heterobicyclic metalloprotease inhibitors
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/06/2010WO2010050781A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010049302A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/06/2010US20100113778 Process for preparing o-chloromethylphenylglyoxylic esters, improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters, and novel intermediates for their preparation
05/06/2010US20100113770 O-substituted hydroxyaryl derivatives
05/06/2010US20100113438 Class of histone deacetylase inhibitors
05/06/2010US20100113418 Heterocyclic compound
05/06/2010CA2779178A1 Analgesic that binds filamin a
05/06/2010CA2741153A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/04/2010US7709474 Enantiomerically pure beta agonists, manufacturing and use thereof
05/04/2010US7709472 treating bacterial infections; 6-{[((1S,5R,6S)-3-{2-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-azabicyclo[3.2.0]hept-6-yl)amino]methyl}-2H-pyrido[3,2-b][1,4]-thiazin-3(4H)-one or -oxazin-3(4H)-one; antibiotics; grampositive Staphylococcus, gramnegative Haemophilus, Moraxella, Escherichia
04/2010
04/29/2010US20100105894 Cyclopropane compounds and pharmaceutical use thereof
04/29/2010US20100105671 C7-fluoro substituted tetracycline compounds
04/29/2010US20100105642 Novel compounds 409
04/29/2010US20100105095 Optical Molecular Sensors for Cytochrome P450 Activity
04/29/2010US20100104979 Alpha-hydroxyketones
04/28/2010EP2179994A1 Fused bicyclic compound
04/28/2010EP1363640B1 Nucleic acid derivatives
04/28/2010CN1658855B O-substituted hydroxyaryl derivatives
04/27/2010US7705008 Prostaglandin analogs
04/27/2010US7705001 Therapeutic substituted gamma lactams
04/27/2010US7704995 Protein kinase modulators and methods of use
04/27/2010CA2493667C Vanilloid receptor ligands and their use in treatments
04/22/2010WO2010043592A1 Lipase inhibitors for use for the treatment of obesity
04/22/2010US20100099867 Process for the preparation of tiotropium bromide
04/22/2010US20100099621 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
04/22/2010US20100098630 Phenazine and Quinoxaline Substituted Amino Acids and Polypeptides
04/22/2010DE102008052618A1 Tricyclische Aldehyde und C,H-acide Verbindungen The tricyclic aldehydes and C, H-acidic compounds
04/21/2010EP2177513A1 Phenylacetic acid compound
04/21/2010EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists
04/21/2010CN101265322B Preparation method of cyano-containing benzoxazine resin
04/20/2010US7700591 to prevent or treat inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis
04/20/2010US7700590 Antibacterial agents
04/20/2010US7700584 antitumor agents; viricides
04/20/2010CA2417475C Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacterien
04/15/2010WO2010042925A2 Compositions and methods for treating alcohol use disorders, pain and other diseases
04/15/2010WO2010042867A2 Activators of human pyruvate kinase
04/15/2010WO2010042475A1 Spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
04/15/2010US20100094001 Composition containing stability-improved chloromethyl phosphate derivative and process for producing same
04/15/2010US20100093713 Beta-carbolines useful for treating inflammatory disease
04/15/2010US20100093707 Acid amide derivatives, process for their production and pesticides containing them
04/15/2010CA2740148A1 Activators of human pyruvate kinase
04/14/2010EP1805170B1 Mif-inhibitors
04/14/2010EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof
04/14/2010EP1477482B1 Novel phenylalanine derivative
04/13/2010US7696246 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin
04/13/2010US7696205 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide
04/13/2010US7696201 e.g. ethyl-4-((2-oxo-1,2-dihydrospiro[benzo[d]1,3]oxazine-4,4'-piperidine]-1'-yl)methyl)piperidine-1-carboxylate; central nervous system disorders; natidepressant, cognition activator, neurodegenerative diseases; obesity, Alzheimer's disease, psychosis, schizophrenia, mania, bipolar disorders
04/13/2010US7696200 4-{[4-(5-Chloro-2-methoxy-benzenesulfonyl)-3,4-dihydro-2H-benzo[1,4]oxazine-6-carbonyl]-amino}-benzoic acid; Type II diabetes; carnitine-dependent palmitoyltransferases (CPTs)
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 112